extends

The antibody treatment emapalumab helps children fare better after stem cell transplants to treat the rare blood disease hemophagocytic lymphohistiocytosis (HLH), according to clinical study results reported in the same …

signature: Valerie Goodwin Newswise — In the United States, approximately 30 to 40 percent of donor hearts are ineligible for transplant due to insufficient donor function. This reduces the number …